CIK: 0002010850 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 15, 2024
Total Value ($000): $422,193 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGON | CG ONCOLOGY INC | 5,478,810 | $206,716 | 49.0% | $40.84 | -14.2% | COM | 156944100 |
| NUVB | Nuvation Bio Inc. | 25,954,439 | $59,436 | 14.1% | $3.05 | -0.0% | COM | 67080N101 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 1,250,000 | $22,600 | 5.4% | $10.33 | +35.3% | COM | 71722W107 |
| RCUS | Arcus Biosciences, Inc | 869,790 | $13,299 | 3.1% | $15.98 | -1.3% | COM | 03969F109 |
| KRYS | KRYSTAL BIOTECH INC | 71,772 | $13,065 | 3.1% | $117.74 | +63.8% | COM | 501147102 |
| ILMN | Illumnia, Inc. | 94,767 | $12,359 | 2.9% | $122.34 | +0.8% | COM | 452327109 |
| ZNTL | Zentalis Pharmaceuticals Inc. | 3,108,095 | $11,438 | 2.7% | $13.39 | -72.9% | COM | 98943L107 |
| BYSI | BeyondSpring Inc. | 4,958,143 | $11,354 | 2.7% | $0.92 | +125.5% | SHS | G10830100 |
| NAMS | NEWAMSTERDAM PHARMA CO NV | 590,000 | $9,794 | 2.3% | $19.17 | -9.8% | COM | N62509109 |
| — | MERUS NV | 189,098 | $9,447 | 2.2% | $51.07 | — | COM | N5749R100 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 166,600 | $8,400 | 2.0% | $50.23 | — | COM | G4444C102 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 157,958 | $8,072 | 1.9% | $39.13 | +31.8% | COM | 22663K107 |
| LEGN | LEGEND BIOTECH CORP-ADR | 108,558 | $5,290 | 1.3% | $54.09 | — | ADR | 52490G102 |
| CYTK | CYTOKINETICS INC | 94,043 | $4,965 | 1.2% | $77.34 | -27.9% | COM | 23282W605 |
| AURA | Aura Biosciences, Inc. | 515,555 | $4,594 | 1.1% | $8.47 | +1.2% | COM | 05153U107 |
| WGS | GeneDx Holdings Corp. | 103,604 | $4,397 | 1.0% | $2.33 | +1352.5% | COM CL A | 81663L200 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 397,835 | $4,301 | 1.0% | $24.39 | -32.0% | COM | 35104E100 |
| EQ | Equillium Inc. | 4,447,308 | $3,700 | 0.9% | $0.59 | +40.4% | COM | 29446K106 |
| VERA | VERA THERAPEUTICS INC | 69,767 | $3,084 | 0.7% | $39.67 | -4.3% | COM | 92337R101 |
| — | LONGBOARD PHARMACEUTICALS IN | 56,350 | $1,878 | 0.4% | $33.33 | — | COM | 54300N103 |
| ACLX | ARCELLX INC | 21,177 | $1,768 | 0.4% | $65.91 | +1.0% | COM | 03940C100 |
| PYXS | Pyxis Oncology, Inc (formerly Apexigen) | 326,810 | $1,199 | 0.3% | $1.71 | +104.4% | COM | 747324101 |
| ATRC | AtriCure Inc. | 26,797 | $751 | 0.2% | $37.19 | -33.7% | COM | 04963C209 |
| GRAL | GRAIL INC | 9,684 | $133 | 0.0% | $16.22 | -6.5% | COM | 384747101 |
| RVMD | REVOLUTION MEDICINES INC(NSM) | 2,000 | $91 | 0.0% | $43.54 | 0.0% | COM | 76155X100 |
| — | Nuvation Bio Inc. | 646,057 | $63 | 0.0% | $0.16 | — | WARRANTS | 67080N119 |